Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

Conditions:   Neoplasms;   Stomach Neoplasms;   Head and Neck Neoplasms
Intervention:   Biological: MK-1697
Sponsor:   Merck Sharp & Dohme Corp.
Not yet recruiting

https://ift.tt/2jt6xDF